CEV currently collecting data in field trials in New Zealand to initiate ProBlad™ dossier registration.
Dossier is expected to be approved by the end of 2027.
Grochem is supporting CEV on ProBlad™ development in New Zealand, and will be the exclusive distributor.
Please click on the link below to know more about Grochem.